Region Hovedstadens Apotek Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2020
NCT04589351
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Capital Region's Pharmacy (Region Hovedstadens Apotek), Marielundvej 25, 2730 Herlev, Denmark | Region Hovedstadens Apotek

Active Ingredients

Drugs in Phase 4 Trials (1)

thiamine (1 trial)

Drugs in Phase 3 Trials (2)

ezetimibe (zetia) (1 trial)

lidocaine (xylocaine) (1 trial)

Drugs in Phase 2 Trials (1)

metformin (glucophage) (1 trial)

Drugs in Phase 1 Trials (2)

cannabidiol (Epidiolex) (1 trial)

tetrahydrocannabinol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Nephropathies (Phase 3)

Kidney Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 6